← Leaderboards
Guo-Fu Hu
Harvard University (Medical School)
$7,212,472
Attributed
$7,212,472
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $631.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,212,472 · 5
By mechanism
R01$6,869,872 · 4
R21$342,600 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- Kevin Struhl$33,571,953
- David A. Sinclair$25,944,681
- Cathy L Miller$1,584,600
- Jessica L Dermody$85,740
Others in their field
Top investigators on “Ribonucleases”
- Feroz R Papa · University Of California San Francisco$15,281,651
- Jeffrey S Glenn · Stanford University$12,895,526
- Susan R. Weiss · University Of Pennsylvania$12,671,617
- Robert H. Silverman · University Of Pennsylvania$11,264,619
- Ronald T Raines · Massachusetts Institute Of Technology$10,760,988
- Joel G. Belasco · New York University School Of Medicine$10,314,736
Research focus
RibonucleasesAngiogeninMediatingPlayGenesRibosomal RnaAnimalsProteinsStressCellsKnockout MiceCell ProliferationGrowthTransgenic MiceCell NucleusAnimal ModelAmyotrophic Lateral SclerosisAngiogenin ReceptorPreventProductionCodeLoss Of Function MutationMessenger RnaGenetic Transcription
Grant awards (24)
Angiogenin and plexin-B2 in therapeutic resistance and disease relapse of GBM$532,321
R01 · FY2025 · CA · contact PI
Protection and mitigation of bone marrow failure by angiogenin$437,032
R01 · FY2020 · HL · contact PI
Protection and mitigation of bone marrow failure by angiogenin$437,032
R01 · FY2019 · HL · contact PI
Protection and mitigation of bone marrow failure by angiogenin$440,783
R01 · FY2018 · HL · contact PI
Protection and mitigation of bone marrow failure by angiogenin$452,032
R01 · FY2017 · HL · contact PI
Mechanism of angiogenin-induced angiogenesis$267,977
R01 · FY2015 · CA · contact PI
Angiogenin in ALS Pathobiology and Therapy$359,732
R01 · FY2014 · NS · contact PI
Mechanism of angiogenin-induced angiogenesis$259,938
R01 · FY2014 · CA · contact PI
Angiogenin in ALS Pathobiology and Therapy$350,647
R01 · FY2013 · NS · contact PI
Mechanism of angiogenin-induced angiogenesis$251,899
R01 · FY2013 · CA · contact PI
Angiogenin in ALS Pathobiology and Therapy$363,365
R01 · FY2012 · NS · contact PI
Mechanism of angiogenin-induced angiogenesis$267,977
R01 · FY2012 · CA · contact PI
Angiogenin in ALS Pathobiology and Therapy$363,365
R01 · FY2011 · NS · contact PI
Mechanism of angiogenin-induced angiogenesis$262,477
R01 · FY2011 · CA · contact PI
Angiogenin in ALS Pathobiology and Therapy$274,000
R01 · FY2010 · NS · contact PI
Angiogenin in ALS Pathobiology and Therapy$96,781
R01 · FY2010 · NS · contact PI
The mechanism of angiogenin-induced angiogenesis$206,174
R01 · FY2009 · CA · contact PI
The mechanism of angiogenin-induced angiogenesis$79,500
R01 · FY2009 · CA · contact PI
The mechanism of angiogenin-induced angiogenesis$285,674
R01 · FY2008 · CA · contact PI
The mechanism of angiogenin-induced angiogenesis$285,674
R01 · FY2007 · CA · contact PI
The mechanism of angiogenin-induced angiogenesis$294,206
R01 · FY2006 · CA · contact PI
The mechanism of angiogenin-induced angiogenesis$301,286
R01 · FY2005 · CA
Inhibition of Angiogenin enhanced rRNA Transcription$170,600
R21 · FY2002 · CA
Inhibition of Angiogenin enhanced rRNA Transcription$172,000
R21 · FY2001 · CA